A5078917104- Cancer, Lipids, and Metabolism
- Neutropenia and Cancer Infections
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- Cancer Treatment and Pharmacology
- Chemotherapy-related skin toxicity
- Estrogen and related hormone effects
- Hematopoietic Stem Cell Transplantation
- Pain Mechanisms and Treatments
- Bone health and treatments
- Hematological disorders and diagnostics
- Blood disorders and treatments
- HER2/EGFR in Cancer Research
- Cancer Genomics and Diagnostics
- Pharmacological Effects and Toxicity Studies
- Liver Disease Diagnosis and Treatment
- Chemotherapy-induced cardiotoxicity and mitigation
- Breast Cancer Treatment Studies
- Lipoproteins and Cardiovascular Health
- Cancer-related Molecular Pathways
- Monoclonal and Polyclonal Antibodies Research
- Cardiac Imaging and Diagnostics
- Viral-associated cancers and disorders
Foundation University Medical College
2016-2025
Foundation University Islamabad
2024
Combined Military Hospital
2021
Manchester Royal Infirmary
2016
Universitat Politècnica de Catalunya
2016
Achievers University
2016
King Saud University
2016
Bone pain is the commonest side-effect faced by cancer patients receiving granulocyte colony stimulating factor (G-CSF) therapy for primary or secondary prevention of febrile neutropenia. We conducted a prospective quasi-experimental study at our setup to see efficacy dual histamine blockade (combined H1 and H2 receptor blockers) preventing G-CSF-induced bone pain. Adult female with solid tumors who had received filgrastim prophylaxis neutropenia met inclusion criteria, were enrolled (n =...
Introduction Ki-67 is a nuclear antigen present in the synthesis phase of cell cycle. Studies have shown that high value results greater response to chemotherapy with higher incidence complete pathological response, which ultimately improved overall survival. Methods and materials The objective study was determine frequency levels breast cancer patients find correlation levels. It descriptive case series correlational design done at Fauji Foundation Hospital Rawalpindi. Eighty locally...
<title>Abstract</title> Purpose: Bone pain is the commonest side-effect faced by cancer patients receiving Granulocyte Colony Stimulating Factor (G-CSF) therapy for primary or secondary prevention of febrile neutropenia. We conducted a prospective quasi-experimental study at our setup to see efficacy dual histamine blockade (combined H1 and H2 blockers) preventing G-CSF-induced bone pains. Methods: Adult female with solid tumors who had received Filgrastim prophylaxis neutropenia met...
Background: According to WHO, breast cancer is the most common in women worldwide, soearly diagnosis best way reduce its morbidity and mortality. Among various risk factors, relationship between serum lipid profile still unclear. Therefore, this study was conducted evaluate relationship. Methodology: Prospective, descriptive observational with a comparative designconducted at Fauji Foundation Hospital, Rawalpindi November 2018 April 2019. Results: 140 patients were divided into two groups...
Introduction: Abnormal lymphoid cells and blast are mononuclear (MNC) circulating in peripheral blood (PB) malignant diseases such as neoplasms acute leukemias.The goal of this work is to build a simple fast classifier recognize automatically among three groups images obtained from PB: 1) MNC 2) granulocytes (G) 3) smudge (SC).This necessary step approach more accurately the segmentation automatic classification MNC.Methods: We created database containing total 57008 digital cell PB 404...
Background:Tamoxifen acts as a selective estrogen receptor modulator by binding to the estrogenreceptors on mammary epithelium andblockingtheproliferative action of mammaryepithelium. In contrast that it has weak agonistic effect bone, liver and endometrium.Tamoxifen therapy favorable effects serum lipid profile decreasing levels Total cholesterol low density lipoprotein (LDL), while its high (HDL) triglyceride (TG)is still controversial. So this study is evaluate tamoxifenTherapy fasting in...